Evidence map›Paper›PMID 34578288›Full record

ArticleViruses2021

Multiple Autonomous Cell Death Suppression Strategies Ensure Cytomegalovirus Fitness.

Pratyusha Mandal, Lynsey N Nagrani, Liliana Hernandez, Anita Louise McCormick, Christopher P Dillon, Heather S Koehler, Linda Roback, Emad S Alnemri, Douglas R Green, Edward S Mocarski

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The role of RHIM in necroptosis.Biochemical Society transactions · 2022
    Article
  13. TAT-RHIM: a more complex issue than expected.The Biochemical journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Pratyusha MandalEmory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0001-6568-4747
Lynsey N NagraniPharmaceutical Product Development, Wilmington, NC 28401, USA.
Liliana HernandezEmory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Anita Louise McCormickBioMarin Pharmaceuticals, Novato, CA 94949, USA.
Christopher P DillonPfizer, San Diego, CA 92121, USA.
Heather S KoehlerEmory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Linda RobackEmory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Emad S AlnemriDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Edward S MocarskiEmory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Emory University · USBioMarin (United States) · USPfizer (United States) · USPharmaceutical Product Development (United States) · USSt. Jude Children's Research Hospital · USThomas Jefferson University · US

Funding

MECHANISMS OF REGULATED CELL DEATHR35CA231620 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Douglas R. Green · 2018 to 2026
$9.2M
CYTOMEGALOVIRUS DNA REPLICATION AND RECOMBINATIONR01AI020211 · NIAID · STANFORD UNIVERSITY · PI EDWARD S MOCARSKI, EDWARD S. · 1985 to 2021
$5.9M
Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT ExtensionR37AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Douglas R. Green · 2017 to 2026
$4.5M
Regulation of the Cell Death Program by DFNA5R01AR074564 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI ALNEMRI, EMAD S · 2019 to 2023
$2.7M
CYTOMEGALOVIRUS PATHOGENESIS IN IMMUNODEFICIENCYR01AI030363 · NIAID · STANFORD UNIVERSITY · PI EDWARD S MOCARSKI, EDWARD S. · 1991 to 2011
$2.7M
3-D Culture ModelsR21AI142507 · NIAID · EMORY UNIVERSITY · PI EDWARD S MOCARSKI, EDWARD S. · 2019 to 2020
$429k
Immune modulation in cytomegalovirus infectionR56AI030363 · NIAID · EMORY UNIVERSITY · PI EDWARD S MOCARSKI, EDWARD S. · 2012 to 2012
$388k
Cytomegalovirus Pathogenesis in ImmunodeficiencyR21AI030363 · NIAID · STANFORD UNIVERSITY · PI MOCARSKI, EDWARD S. · 2001 to 2001
$277k
National Institute of Allergy and Infectious Diseases AI020211National Institute of Allergy and Infectious Diseases AI030363National Institute of Allergy and Infectious Diseases AI142507NCI NIH HHS R35 CA231620NIAID NIH HHS R37 AI044828NIAMS NIH HHS R01 AR074564
6 · The paper itself

Abstract

Programmed cell death pathways eliminate infected cells and regulate infection-associated inflammation during pathogen invasion. Cytomegaloviruses encode several distinct suppressors that block intrinsic apoptosis, extrinsic apoptosis, and necroptosis, pathways that impact pathogenesis of this ubiquitous herpesvirus. Here, we expanded the understanding of three cell autonomous suppression mechanisms on which murine cytomegalovirus relies: (i) M38.5-encoded viral mitochondrial inhibitor of apoptosis (vMIA), a BAX suppressor that functions in concert with M41.1-encoded viral inhibitor of BAK oligomerization (vIBO), (ii) M36-encoded viral inhibitor of caspase-8 activation (vICA), and (iii) M45-encoded viral inhibitor of RIP/RHIM activation (vIRA). Following infection of bone marrow-derived macrophages, the virus initially deflected receptor-interacting protein kinase (RIPK)3-dependent necroptosis, the most potent of the three cell death pathways. This process remained independent of caspase-8, although suppression of this apoptotic protease enhances necroptosis in most cell types. Second, the virus deflected TNF-mediated extrinsic apoptosis, a pathway dependent on autocrine TNF production by macrophages that proceeds independently of mitochondrial death machinery or RIPK3. Third, cytomegalovirus deflected BCL-2 family protein-dependent mitochondrial cell death through combined TNF-dependent and -independent signaling even in the absence of RIPK1, RIPK3, and caspase-8. Furthermore, each of these cell death pathways dictated a distinct pattern of cytokine and chemokine activation. Therefore, cytomegalovirus employs sequential, non-redundant suppression strategies to specifically modulate the timing and execution of necroptosis, extrinsic apoptosis, and intrinsic apoptosis within infected cells to orchestrate virus control and infection-dependent inflammation. Virus-encoded death suppressors together hold control over an intricate network that upends host defense and supports pathogenesis in the intact mammalian host.

Indexed as

Cell DeathSignal TransductionAnimalsCaspase 8MacrophagesMiceMice, Inbred BALB CMice, Inbred C57BLMitochondriaMuromegalovirusViral ProteinsCaspase 8Viral ProteinsapoptosisBCL2 familycell deathcmvPCDcytomegalovirusDNA virusextrinsic apoptosisHCMVherpesvirusIFNinflammationintrinsic apoptosisM36M38.5M41.1M45macrophagesMCMVmitochondriamyeloid cellsnecroptosispyroptosisreplicationRIPK1RIPK3serine proteaseTNFUL36vIBO Caspase-8vICAvIRAvMIA

Identifiers

PMID34578288
PMCPMC8473406
OpenAlexW3197582067

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.